{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:26:00Z","timestamp":1791483960318,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T00:00:00Z","timestamp":1261008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00259-009-1332-5","type":"journal-article","created":{"date-parts":[[2009,12,16]],"date-time":"2009-12-16T11:07:45Z","timestamp":1260961665000},"page":"942-953","source":"Crossref","is-referenced-by-count":109,"title":["Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[11C]verapamil PET"],"prefix":"10.1007","volume":"37","author":[{"given":"Claudia","family":"Kuntner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens P.","family":"Bankstahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Bankstahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Stanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Stundner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Karch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Brauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,17]]},"reference":[{"issue":"1","key":"1332_CR1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pneurobio.2005.04.006","volume":"76","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher W, Potschka H. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog Neurobiol 2005;76(1):22\u201376.","journal-title":"Prog Neurobiol"},{"issue":"2","key":"1332_CR2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.jcbfm.9600349","volume":"27","author":"M Lubberink","year":"2007","unstructured":"Lubberink M, Luurtsema G, van Berckel BN, Boellaard R, Toornvliet R, Windhorst AD, et al. Evaluation of tracer kinetic models for quantification of P-glycoprotein function using (R)-[(11)C]verapamil and PET. J Cereb Blood Flow Metab 2007;27(2):424\u201333.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"1332_CR3","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2967\/jnumed.108.051235","volume":"49","author":"JP Bankstahl","year":"2008","unstructured":"Bankstahl JP, Kuntner C, Abrahim A, Karch R, Stanek J, Wanek T, et al. Tariquidar-induced P-glycoprotein inhibition at the rat blood-brain barrier studied with (R)-11C-verapamil and PET. J Nucl Med 2008;49(8):1328\u201335.","journal-title":"J Nucl Med"},{"issue":"3","key":"1332_CR4","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S1053-8119(03)00405-1","volume":"20","author":"J Bart","year":"2003","unstructured":"Bart J, Willemsen AT, Groen HJ, van der Graaf WT, Wegman TD, Vaalburg W, et al. Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET. Neuroimage 2003;20(3):1775\u201382.","journal-title":"Neuroimage"},{"issue":"6","key":"1332_CR5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.parkreldis.2007.11.007","volume":"14","author":"AL Bartels","year":"2008","unstructured":"Bartels AL, van Berckel BN, Lubberink M, Luurtsema G, Lammertsma AA, Leenders KL. Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson\u2019s disease. Parkinsonism Relat Disord 2008;14(6):505\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"1332_CR6","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.1528-1167.2007.01116.x","volume":"48","author":"O Langer","year":"2007","unstructured":"Langer O, Bauer M, Hammers A, Karch R, Pataraia E, Koepp MJ, et al. Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil. Epilepsia 2007;48(9):1774\u201384.","journal-title":"Epilepsia"},{"issue":"2","key":"1332_CR7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1124\/jpet.105.088328","volume":"316","author":"YJ Lee","year":"2006","unstructured":"Lee YJ, Maeda J, Kusuhara H, Okauchi T, Inaji M, Nagai Y, et al. In vivo evaluation of P-glycoprotein function at the blood-brain barrier in nonhuman primates using [11C]verapamil. J Pharmacol Exp Ther 2006;316(2):647\u201353.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"1332_CR8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.clpt.2005.01.022","volume":"77","author":"L Sasongko","year":"2005","unstructured":"Sasongko L, Link JM, Muzi M, Mankoff DA, Yang X, Collier AC, et al. Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography. Clin Pharmacol Ther 2005;77(6):503\u201314.","journal-title":"Clin Pharmacol Ther"},{"key":"1332_CR9","doi-asserted-by":"crossref","unstructured":"Wagner CC, Bauer M, Karch R, Feurstein T, Kopp S, Chiba P, et al. A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PET. J Nucl Med 2009; in press.","DOI":"10.2967\/jnumed.109.063289"},{"issue":"2","key":"1332_CR10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clpt.2005.04.011","volume":"78","author":"M Brunner","year":"2005","unstructured":"Brunner M, Langer O, Sunder-Plassmann R, Dobrozemsky G, M\u00fcller U, Wadsak W, et al. Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humans. Clin Pharmacol Ther 2005;78(2):182\u201390.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"1332_CR11","first-page":"455","volume":"46","author":"YC Tai","year":"2005","unstructured":"Tai YC, Ruangma A, Rowland D, Siegel S, Newport DF, Chow PL, et al. Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging. J Nucl Med 2005;46(3):455\u201363.","journal-title":"J Nucl Med"},{"issue":"2","key":"1332_CR12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-3565(24)39245-6","volume":"293","author":"C Pauli-Magnus","year":"2000","unstructured":"Pauli-Magnus C, von Richter O, Burk O, Ziegler A, Mettang T, Eichelbaum M, et al. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein. J Pharmacol Exp Ther 2000;293(2):376\u201382.","journal-title":"J Pharmacol Exp Ther"},{"key":"1332_CR13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00259-007-0556-5","volume":"35","author":"A Abrahim","year":"2008","unstructured":"Abrahim A, Luurtsema G, Bauer M, Karch R, Lubberink M, Pataraia E, et al. Peripheral metabolism of (R)-[(11)C]verapamil in epilepsy patients. Eur J Nucl Med Mol Imaging 2008;35:116\u201323.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1332_CR14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nucmedbio.2004.06.007","volume":"32","author":"G Luurtsema","year":"2005","unstructured":"Luurtsema G, Molthoff CF, Schuit RC, Windhorst AD, Lammertsma AA, Franssen EJ. Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood-brain barrier: kinetics and metabolism in the rat. Nucl Med Biol 2005;32(1):87\u201393.","journal-title":"Nucl Med Biol"},{"issue":"3","key":"1332_CR15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1162\/153535003322556877","volume":"2","author":"AM Loening","year":"2003","unstructured":"Loening AM, Gambhir SS. AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2003;2(3):131\u20137.","journal-title":"Mol Imaging"},{"issue":"2","key":"1332_CR16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bjp.0702807","volume":"128","author":"C Martin","year":"1999","unstructured":"Martin C, Berridge G, Mistry P, Higgins C, Charlton P, Callaghan R. The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein. Br J Pharmacol 1999;128(2):403\u201311.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1332_CR17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3565(24)29270-3","volume":"299","author":"JW Polli","year":"2001","unstructured":"Polli JW, Wring SA, Humphreys JE, Huang L, Morgan JB, Webster LO, et al. Rational use of in vitro P-glycoprotein assays in drug discovery. J Pharmacol Exp Ther 2001;299(2):620\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"1332_CR18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1124\/jpet.105.099648","volume":"317","author":"EF Choo","year":"2006","unstructured":"Choo EF, Kurnik D, Muszkat M, Ohkubo T, Shay SD, Higginbotham JN, et al. Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier. J Pharmacol Exp Ther 2006;317(3):1012\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"1332_CR19","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/jps.20658","volume":"95","author":"L Cutler","year":"2006","unstructured":"Cutler L, Howes C, Deeks NJ, Buck TL, Jeffrey P. Development of a P-glycoprotein knockout model in rodents to define species differences in its functional effect at the blood-brain barrier. J Pharm Sci 2006;95(9):1944\u201353.","journal-title":"J Pharm Sci"},{"issue":"4","key":"1332_CR20","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/jm8013822","volume":"52","author":"M K\u00fchnle","year":"2009","unstructured":"K\u00fchnle M, Egger M, M\u00fcller C, Mahringer A, Bernhardt G, Fricker G, et al. Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar. J Med Chem 2009;52(4):1190\u20137.","journal-title":"J Med Chem"},{"issue":"3","key":"1332_CR21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1124\/dmd.108.024745","volume":"37","author":"S Syv\u00e4nen","year":"2009","unstructured":"Syv\u00e4nen S, Lindhe O, Palner M, Kornum BR, Rahman O, L\u00e5ngstr\u00f6m B, et al. Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport. Drug Metab Dispos 2009;37(3):635\u201343.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"1332_CR22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2967\/jnumed.108.056226","volume":"50","author":"JS Liow","year":"2009","unstructured":"Liow JS, Kreisl W, Zoghbi SS, Lazarova N, Seneca N, Gladding RL, et al. P-glycoprotein function at the blood-brain barrier imaged using 11C-N-desmethyl-loperamide in monkeys. J Nucl Med 2009;50(1):108\u201315.","journal-title":"J Nucl Med"},{"issue":"1","key":"1332_CR23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/jpet.107.121178","volume":"322","author":"EA Vliet van","year":"2007","unstructured":"van Vliet EA, van Schaik R, Edelbroek PM, Voskuyl RA, Redeker S, Aronica E, et al. Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats. J Pharmacol Exp Ther 2007;322(1):141\u20137.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1332_CR24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eplepsyres.2003.12.009","volume":"58","author":"HA Volk","year":"2004","unstructured":"Volk HA, Potschka H, L\u00f6scher W. Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats. Epilepsy Res 2004;58(1):67\u201379.","journal-title":"Epilepsy Res"},{"issue":"12","key":"1332_CR25","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00259-008-0832-z","volume":"35","author":"G La\u0107an","year":"2008","unstructured":"La\u0107an G, Plenevaux A, Rubins DJ, Way BM, Defraiteur C, Lemaire C, et al. Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies. Eur J Nucl Med Mol Imaging 2008;35(12):2256\u201366.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 2","key":"1332_CR26","first-page":"223P","volume":"50","author":"M Bauer","year":"2009","unstructured":"Bauer M, Wagner CC, Kletter K, Zeitlinger M, M\u00fcller M, Langer O. Regional differences in P-glycoprotein function at the human blood-brain barrier [symposium abstract]. J Nucl Med 2009;50(Suppl 2):223P.","journal-title":"J Nucl Med"},{"key":"1332_CR27","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"2007","unstructured":"Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. London: Academic; 2007.","edition":"6"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1332-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-009-1332-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1332-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T21:24:39Z","timestamp":1739481879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-009-1332-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,17]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["1332"],"URL":"https:\/\/doi.org\/10.1007\/s00259-009-1332-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,17]]}}}